Endpoints News 生物医药· Nicole DeFeudis·· 2026-10-14AI 评分32
FTC 指控 Martin Shkreli 违反终身制药禁令
FTC accuses Martin Shkreli of violating lifetime pharma ban
AI 导读
FTC 与七个州周二请求纽约联邦法院判定 Martin Shkreli 违反终身制药禁令。这是 Shkreli 再次接受 FTC 审查。
正文
Martin Shkreli is under FTC scrutiny once again.
The agency and seven states asked a New York federal court on Tuesday to hold Shkreli in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news